Holen Sie sich die Stockscreener-App
8.47
4.72%
-0.42
Handel nachbörslich:
8.47
Schlusskurs vom Vortag:
$8.89
Offen:
$8.83
24-Stunden-Volumen:
1.50M
Relative Volume:
1.15
Marktkapitalisierung:
$346.56M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-10.33
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
-7.43%
1M Leistung:
+6.94%
6M Leistung:
-68.47%
1J Leistung:
-84.28%
1-Tages-Spanne:
$8.29
$8.8494
1-Wochen-Bereich:
$8.29
$9.25
52-Wochen-Spanne:
$6.32
$57.53
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
8.47 | 355.97M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight, Inc. (NASDAQ: RXST) Investor Alert: Deadline in Lawsuit on September 22, 2025 - openPR.com
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Using economic indicators to assess RxSight Inc. potentialDollar Strength & Pattern Based Trade Signal System - Newser
Shareholders that lost money on RxSight, Inc.(RXST) Urged - GlobeNewswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
Securities Fraud Class Action Filed Against RxSight, Inc. (RXST)Levi & Korsinsky Reminds Investors of September 22, 2025 - ACCESS Newswire
Is it time to cut losses on RxSight Inc.Market Activity Summary & Fast Moving Market Watchlists - Newser
Can momentum traders help lift RxSight Inc.Watch List & Trade Opportunity Analysis Reports - Newser
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Notifies RxSight, Inc. (RXST) Shareholders of Class Action Lawsuit and September 22, 2025 Deadline - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - FinancialContent
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein - GlobeNewswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
RXST FRAUD ALERT: Did RxSight, Inc. Mislead Investors? - GlobeNewswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - MarketScreener
RXST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Applying chart zones and confluence areas to RxSight Inc.Inflation Watch & Long Hold Capital Preservation Plans - Newser
RXSIGHT NOTICE: BFA Law Notifies RxSight, Inc. Investors of - GlobeNewswire
Securities Lawsuit Alert: RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
Securities Class Action Lawsuit Filed Against RxSight, Inc. (RXST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Will earnings trigger a reversal in RxSight Inc.Swing Trade & Long-Term Safe Investment Ideas - Newser
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
RXST SHAREHOLDERS: RxSight, Inc. Investors may have been - GlobeNewswire
RxSight (RXST) and the Implications of Its Class-Action Lawsuit on Shareholder Value and Risk Management - AInvest
How to interpret RSI for RxSight Inc. stockJuly 2025 Decliners & AI Optimized Trading Strategy Guides - Newser
How to use Fibonacci retracement on RxSight Inc.Earnings Summary Report & Weekly Stock Performance Updates - Newser
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - Morningstar
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Levi & Korsinsky Reminds RxSight, Inc. Investors of the - GlobeNewswire
Market reaction to RxSight Inc.’s recent news2025 Dividend Review & Risk Managed Investment Strategies - Newser
Securities Law Risks in Emerging Medtech Stocks: A Governance and Litigation Analysis of RxSight, Inc. - AInvest
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
Published on: 2025-08-28 20:20:28 - Newser
Levi & Korsinsky Moves to SueWallSt For RxSight, Inc. Investors That Lost Money - ACCESS Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rxsight Inc-Aktie (RXST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
| Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):